Read + Share
Amedeo Smart
Independent Medical Education
Godfrey J, Mei M, Chen L, Song JY, et al. Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma. Haematologica 2023 Jul 20. doi: 10.3324/haematol.2023.283002.PMID: 37470137
Email
LinkedIn
Facebook
Twitter
Privacy Policy